Episode Details
Back to Episodes
Daily Roundup | Vera's TRUTAKNA Wins FDA Nod: The eGFR Readout That Decides the IgAN Race
Published 2 weeks, 2 days ago
Description
Vera Therapeutics wins FDA accelerated approval for TRUTAKNA (atacicept) in IgA nephropathy on a 42% placebo-adjusted proteinuria cut — setting up a head-to-head with Otsuka's VOYXACT. Plus Oberland Capital's up-to-$400M royalty deal for MeiraGTx eye gene therapies, Novartis cuts 322 New Jersey jobs, Bristol Myers' Krazati confirmatory failure in colorectal cancer, Roche's divarasib KRAS win, and Teva's early repigmentation data.
Visit us at thepharmacloseout.com.